{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:38:29Z","timestamp":1790735909162,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Preeclampsia (PE) generally manifests in the second half of pregnancy with hypertension and proteinuria. The understanding of the origin and mechanism behind PE is incomplete, although there is clearly an immune component to this disorder. The placenta constitutes a complicated immune interface between fetal and maternal cells, where regulation and tolerance are key. Stress factors from placental dysfunction in PE are released to the maternal circulation evoking the maternal response. Several complement factors play a role within this intricate landscape, including C1q in vascular remodeling and Factor H (FH) as the key regulator of alternative pathway complement activation. We hypothesize that decreased levels of C1q or FH, or disturbance of their function by autoantibodies, may be associated with PE. Autoantibodies against C1q and FH and the concentrations of C1q and FH were measured by ELISA in maternal sera from women with preeclamptic and normal pregnancies. Samples originated from cohorts collected in the Netherlands (n=63 PE; n=174 control pregnancies, n=51 nonpregnant), Finland (n=181 PE; n=63 control pregnancies) and Norway (n=59 PE; n=27 control pregnancies). Serum C1q and FH concentrations were higher in control pregnancy than in nonpregnant women. No significant differences were observed for serum C1q between preeclamptic and control pregnancy in any of the three cohorts. Serum levels of FH were lower in preeclamptic pregnancies compared to control pregnancies in two of the cohorts, this effect was driven by the early onset PE cases. Neither anti-C1q autoantibodies nor anti-FH autoantibodies levels differed between women with PE and normal pregnancies. In conclusion, levels of anti-C1q and anti-FH autoantibodies are not increased in PE. C1q and FH are increased in pregnancy, but importantly, a decrease in FH concentration is associated with PE.<\/jats:p>","DOI":"10.3389\/fimmu.2022.842451","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T10:48:30Z","timestamp":1667990910000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia"],"prefix":"10.3389","volume":"13","author":[{"given":"Douwe Jan","family":"Dijkstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Inkeri","family":"Lokki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lobke Marijn","family":"Gierman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Veronique","family":"Borggreven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin","family":"van der Keur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eikmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra Andrea","family":"Gelderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannele","family":"Laivuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The FINNPEC Core Investigator Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Charlotte","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise P.","family":"van der Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert Adrianus","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of Preeclampsia: Risk Factors and Outcomes Associated With Early- Versus Late-Onset Disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1111726","article-title":"Latest Advances in Understanding Preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-Eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of Two Parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: A Key System for Immune Surveillance and Homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R","article-title":"Direct Binding of C1q to Apoptotic Cells and Cell Blebs Induces Complement Activation","volume":"32","author":"Nauta","year":"2002","journal-title":"Eur J Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903215","article-title":"An Alternative Role of C1q in Cell Migration and Tissue Remodeling: Contribution to Trophoblast Invasion and Placental Development","volume":"185","author":"Agostinis","year":"2010","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.175919","article-title":"Role of Complement Component C1q in the Onset of Preeclampsia in Mice","volume":"58","author":"Singh","year":"2011","journal-title":"Hypertension"},{"key":"B9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jri.2016.09.001","article-title":"Alternative Functions of the Complement Protein C1q at Embryo Implantation Site","volume":"119","author":"Agostinis","year":"2017","journal-title":"J Reprod Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00647","article-title":"C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus","volume":"7","author":"van Schaarenburg","year":"2016","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M704354200","article-title":"C4b-Binding Protein and Factor H Compensate for the Loss of Membrane-Bound Complement Inhibitors to Protect Apoptotic Cells Against Excessive Complement Attack","volume":"282","author":"Trouw","year":"2007","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement Activation and Regulation in Preeclamptic Placenta","volume":"5","author":"Lokki","year":"2014","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2021.03.006","article-title":"Pregnancy Induced TMA in Severe Preeclampsia Results From Complement-Mediated Thromboinflammation","volume":"82","author":"Lokki","year":"2021","journal-title":"Hum Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.05.009","article-title":"Autoantibodies Against Complement Components and Functional Consequences","volume":"56","author":"Dragon-Durey","year":"2013","journal-title":"Mol Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200311000-00008","article-title":"Diagnostic and Prognostic Significance of Anti-C1q Antibodies in Systemic Lupus Erythematosus","volume":"12","author":"Seelen","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421075","article-title":"Anti-C1q Autoantibodies Deposit in Glomeruli But Are Only Pathogenic in Combination With Glomerular C1q-Containing Immune Complexes","volume":"114","author":"Trouw","year":"2004","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.10.010","article-title":"Circulating C1q Levels in Health and Disease, More Than Just a Biomarker","volume":"140","author":"van de Bovenkamp","year":"2021","journal-title":"Mol Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150185","article-title":"Factor H Autoantibodies in Patients With Antiphospholipid Syndrome and Thrombosis","volume":"42","author":"Foltyn Zadura","year":"2015","journal-title":"J Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402770","article-title":"Anti-Factor H Autoantibodies in C3 Glomerulopathies and in Atypical Hemolytic Uremic Syndrome: One Target, Two Diseases","volume":"194","author":"Blanc","year":"2015","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12813","article-title":"Anti-C1q Autoantibodies Are Linked to Autoimmune Thyroid Disorders in Pregnant Women","volume":"186","author":"Vitkova","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-015-3144-x","article-title":"Incidence of Autoantibodies to C1Q Complement Component in Women With Miscarriages and Autoantibodies to Phospholipids and Chorionic Gonadotropin","volume":"160","author":"Menzhinskaya","year":"2015","journal-title":"Bull Exp Biol Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"637513","DOI":"10.1155\/2013\/637513","article-title":"Interleukin-15 (IL-15) and Anti-C1q Antibodies as Serum Biomarkers for Ectopic Pregnancy and Missed Abortion","volume":"2013","author":"Daponte","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jaut.2016.06.012","article-title":"Maternal Outcome in Pregnant Women With Lupus Nephritis. A Prospective Multicenter Study","volume":"74","author":"Moroni","year":"2016","journal-title":"J Autoimmun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e013148","DOI":"10.1136\/bmjopen-2016-013148","article-title":"Cohort Profile: The Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC)","volume":"6","author":"J\u00e4\u00e4skel\u00e4inen","year":"2016","journal-title":"BMJ Open"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02427","article-title":"Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis","volume":"9","author":"Lubbers","year":"2018","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.11.062","article-title":"Low Plasma HLA-G Protein Concentrations in Early Gestation Indicate the Development of Preeclampsia Later in Pregnancy","volume":"193","author":"Yie","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.06.033","article-title":"Reduced Third-Trimester Levels of Soluble Human Leukocyte Antigen G Protein in Severe Preeclampsia","volume":"197","author":"Hackmon","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13377","article-title":"Low Expression of Soluble Human Leukocyte Antigen G in Early Gestation and Subsequent Placenta-Mediated Complications of Pregnancy","volume":"43","author":"Marozio","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.biopha.2017.01.016","article-title":"Immune Regulatory Network in Successful Pregnancy and Reproductive Failures","volume":"88","author":"Ghaebi","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B30","doi-asserted-by":"publisher","first-page":"102872","DOI":"10.1016\/j.ebiom.2020.102872","article-title":"Fetal HLA-G Mediated Immune Tolerance and Interferon Response in Preeclampsia","volume":"59","author":"Wedenoja","year":"2020","journal-title":"EBioMedicine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103760","article-title":"Complement Protein C1q Directs Macrophage Polarization and Limits Inflammasome Activity During the Uptake of Apoptotic Cells","volume":"188","author":"Benoit","year":"2012","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.915777","article-title":"Serum Levels of Complement Factors C1q, Bb, and H in Normal Pregnancy and Severe Pre-Eclampsia","volume":"25","author":"Jia","year":"2019","journal-title":"Med Sci Monit"},{"key":"B33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molimm.2020.03.021","article-title":"Dysregulation of Complement System During Pregnancy in Patients With Preeclampsia: A Prospective Study","volume":"122","author":"He","year":"2020","journal-title":"Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the Complement System in Normal Pregnancy and Preeclampsia","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/aji.12162","article-title":"Maternal and Fetal Alternative Complement Pathway Activation in Early Severe Preeclampsia","volume":"71","author":"Hoffman","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative Complement Pathway Activation Fragment Bb in Early Pregnancy as a Predictor of Preeclampsia","volume":"198","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PloS Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.orcp.2017.11.002","article-title":"Longitudinal Associations of the Alternative and Terminal Pathways of Complement Activation With Adiposity: The CODAM Study","volume":"12","author":"Xin","year":"2018","journal-title":"Obes Res Clin Pract"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0700","article-title":"Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance","volume":"59","author":"Moreno-Navarrete","year":"2010","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.186","article-title":"New Insights Into the Immunopathogenesis of Systemic Lupus Erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500455","article-title":"The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells","volume":"196","author":"Olivar","year":"2016","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.842451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T10:48:32Z","timestamp":1667990912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.842451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2022.842451"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.842451","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"article-number":"842451"}}